ELISA binding curve showing the dose-dependent interaction between biotinylated Human CLEC9A, hFc Tag, and Anti-CLEC9A Antibody, hFc Tag. The plot presents mean absorbance (OD450) versus the log concentration of biotinylated Human CLEC9A (µg/ml), demonstrating a sigmoidal response.
Biotinylated Human CLEC9A Protein (Primary Amine Labeling) (CLE-HM29AB)
  • Express System: HEK293
  • Product Tag: N-hFc
  • Purity: > 95% as determined by Bis-Tris PAGE;> 90% as determined by HPLC
  • Activity: Immobilized Anti-CLEC9A Antibody, hFc Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human CLEC9A, hFc Tag with the EC50 of 30.9ng/ml determined by ELISA (QC Test). See testing image for detail.
  • Amino Acid Range: Lys57-Val241
Catalog #CLE-HM29AB
Regular price $577.50
/
Size

Order now, ships by:

Biotinylated Human CLEC9A Protein (Primary Amine Labeling) (CLE-HM29AB) Summary

Product Description

Recombinant Biotinylated Human CLEC9A Protein (Primary Amine Labeling) is expressed from HEK293 with hFc tag at the N-terminus.It contains Lys57-Val241.

Product Background

CLEC9A is a recently discovered C-type lectin receptor involved in sensing necrotic cells. In humans, this receptor is selectively expressed by BDCA3(+) myeloid dendritic cells (mDCs), which have been proposed to be the main human cross-presenting mDCs and may represent the human homologue of murine CD8(+) DCs. In mice, it was demonstrated that antigens delivered with antibodies to CLEC9A are presented by CD8(+) DCs to both CD4(+) and CD8(+) T cells and induce antitumor immunity in a melanoma model.

Product Category

Recombinant Protein / Antibody discovery / Antibody discovery | Others

Biotinylated Human CLEC9A Protein (Primary Amine Labeling) (CLE-HM29AB) Specifications/Details

Protein
CLEC9A
Synonyms
CD370; CLEC9A; 9830005G06Rik; DNGR-1; HEEE9341; UNQ9341
Accession
Species
Human
Biotinylated
yes
Amino Acid Range
Lys57-Val241
Molecular Weight
The protein has a predicted MW of 48.5 kDa. Due to glycosylation, the protein migrates to 55-70 kDa based on Bis-Tris PAGE result.
Activity
Immobilized Anti-CLEC9A Antibody, hFc Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human CLEC9A, hFc Tag with the EC50 of 30.9ng/ml determined by ELISA (QC Test). See testing image for detail.

Product Tag

N-hFc
Expression System
HEK293
Purity
> 95% as determined by Bis-Tris PAGE;> 90% as determined by HPLC
Endotoxin
Less than 1 EU per ug by the LAL method.
Form
Lyophilized
Shipping
Shipped at ambient temperature.
Formulation
Lyophilized from 0.22 um filtered solution in PBS, 100mM L-arginine (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution
Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 ug or less, at 1mg/ml for 500ug or 1mg lyophilized powder. Do not mix by vortex or vigorous shaking.
Stability And Storage
-20 to -80°C for 12 months as supplied from date of receipt.;-80°C for 3 months after reconstitution.;Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Immobilized Anti-CLEC9A Antibody, hFc Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human CLEC9A, hFc Tag with the EC50 of 30.9ng/ml determined by ELISA (QC Test). Immobilized Anti-CLEC9A Antibody, hFc Tag at 0.5ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human CLEC9A, hFc Tag with the EC50 of 30.9ng/ml determined by ELISA (QC Test).
Biotinylated Human CLEC9A on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. Biotinylated Human CLEC9A on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Biotinylated Human CLEC9A is greater than 90% as determined by SEC-HPLC. The purity of Biotinylated Human CLEC9A is greater than 90% as determined by SEC-HPLC.
Have more questions?

Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.

Recently viewed